Literature DB >> 1672157

Biologically active taxol analogues with deleted A-ring side chain substituents and variable C-2' configurations.

C S Swindell1, N E Krauss, S B Horwitz, I Ringel.   

Abstract

Taxol, a potent inhibitor of cell replication, enhances the assembly of tubulin into stable microtubules and promotes the formation of microtubule bundles in cells. In addition to its unique mechanism of action, taxol exhibits unusual promise as an antitumor agent, but its application in cancer chemotherapy is hampered by its limited availability. In order to better define the structure-activity profile of taxol for the design of more accessible drugs and to provide insight into the chemical features of the taxol-microtubule interaction, taxol analogues 3-8, with deleted A-ring side chain substituents and both R and S C-2' configurations, were synthesized from baccatin III through esterification at the hindered 13-hydroxyl. Employing an improved hydroxyl protection strategy, lactate analogues 3 and 4 were prepared with reasonable efficiency owing to their simple side-chain structures, while N-benzoylisoserine analogues 7 and 8 were synthesized through esterification reactions whose rates were enhanced greatly by the participation of the amide functionality. Although less biologically active than taxol, analogues 5-7 were found to promote the polymerization of tubulin and to be cytotoxic; 5 and 6 were considerably more effective than 7, whereas 3, 4, and 8 were least active. Interestingly, tubulin polymerization was sensitive to the C-2' configuration only when the amide substituent was present in the side chain. This observation suggests that the 3'-amide substituent plays an important role in preorganizing the taxol side chain to bind to microtubules.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1672157     DOI: 10.1021/jm00107a042

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  14 in total

1.  The binding conformation of Taxol in beta-tubulin: a model based on electron crystallographic density.

Authors:  J P Snyder; J H Nettles; B Cornett; K H Downing; E Nogales
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

2.  Development of paclitaxel-TyroSpheres for topical skin treatment.

Authors:  Brian E Kilfoyle; Larisa Sheihet; Zheng Zhang; Marissa Laohoo; Joachim Kohn; Bozena B Michniak-Kohn
Journal:  J Control Release       Date:  2012-06-23       Impact factor: 9.776

3.  Physiologically-based modeling and interspecies prediction of paclitaxel pharmacokinetics.

Authors:  Xiaowei Zang; Leonid Kagan
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-04-18       Impact factor: 2.745

4.  Prevention of paclitaxel-induced neuropathy by formulation approach.

Authors:  Xiaowei Zang; Jong Bong Lee; Kiran Deshpande; Olga B Garbuzenko; Tamara Minko; Leonid Kagan
Journal:  J Control Release       Date:  2019-04-11       Impact factor: 9.776

5.  Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines.

Authors:  L R Kelland; G Abel
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

6.  Antifungal properties of taxol and various analogues.

Authors:  D H Young; E L Michelotti; C S Swindell; N E Krauss
Journal:  Experientia       Date:  1992-09-15

7.  Understanding tubulin-Taxol interactions: mutations that impart Taxol binding to yeast tubulin.

Authors:  Mohan L Gupta; Claudia J Bode; Gunda I Georg; Richard H Himes
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-09       Impact factor: 11.205

8.  Novel taxol formulations: preparation and characterization of taxol-containing liposomes.

Authors:  A Sharma; R M Straubinger
Journal:  Pharm Res       Date:  1994-06       Impact factor: 4.200

9.  Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited.

Authors:  Peisheng Xu; Emily Gullotti; Ling Tong; Christopher B Highley; Divya R Errabelli; Tayyaba Hasan; Ji-Xin Cheng; Daniel S Kohane; Yoon Yeo
Journal:  Mol Pharm       Date:  2009 Jan-Feb       Impact factor: 4.939

Review 10.  Recent advances in the study of the bioactive conformation of taxol.

Authors:  Liang Sun; Carlos Simmerling; Iwao Ojima
Journal:  ChemMedChem       Date:  2009-05       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.